Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basophil histamine release refers to the process by which basophils, a type of white blood cell, secrete histamine in response to various stimuli. This release is a key event in allergic reactions and immune responses, contributing to inflammation and other physiological effects. The classic trigger is cross-linking of IgE antibodies bound to FcεRI receptors by specific antigens. Other triggers include calcium ionophores and platelet-derived factors. The process can be modulated by intracellular signaling pathways, and dysregulation contributes directly to symptoms seen in allergic rhinitis, asthma exacerbations, urticaria, anaphylaxis, and other hypersensitivity disorders.
N/A (This is a process, not a target)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basophil Histamine Release (BHR).